METHODS FOR LOWERING BLOOD SUGAR WITH A DIPEPTIDYL PEPTIDASE-4 INHIBITOR PHARMACEUTICAL COMPOSITION

A method is provided for lowering blood sugar in a subject in need thereof by administering a dipeptidyl peptidase-4 inhibitor pharmaceutical composition to a subject qualified for over-the-counter access to the dipeptidyl peptidase-4 inhibitor pharmaceutical composition. In some embodiments, the di...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FIROR, Judy, PRYBOLSKY, Robert
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA HUMAN NECESSITIES HYGIENE INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS MEDICAL OR VETERINARY SCIENCE PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A method is provided for lowering blood sugar in a subject in need thereof by administering a dipeptidyl peptidase-4 inhibitor pharmaceutical composition to a subject qualified for over-the-counter access to the dipeptidyl peptidase-4 inhibitor pharmaceutical composition. In some embodiments, the dipeptidyl peptidase-4 inhibitor pharmaceutical composition includes saxagliptin, sitagliptin, linagliptin, alogliptin, or a pharmaceutically acceptable salt thereof. In some embodiments, the dipeptidyl peptidase-4 inhibitor pharmaceutical composition includes (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1- adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile or a pharmaceutically acceptable salt thereof. L'invention concerne un procédé pour abaisser la glycémie chez un sujet en ayant besoin par l'administration d'une composition pharmaceutique d'inhibiteur de la dipeptidylpeptidase-4 à un sujet pouvant bénéficier d'un accès sans ordonnance à la composition pharmaceutique d'inhibiteur de la dipeptidylpeptidase-4. Dans certains modes de réalisation, la composition pharmaceutique d'inhibiteur de la dipeptidylpeptidase-4 comprend de la saxagliptine, de la sitagliptine, de la linagliptine, de l'alogliptine ou un sel pharmaceutiquement acceptable de celles-ci. Dans certains modes de réalisation, la composition pharmaceutique d'inhibiteur de la dipeptidylpeptidase-4 comprend un (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acétyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile ou un sel pharmaceutiquement acceptable de celui-ci.